Comprehensive-targeted lipidomic analysis in Niemann-Pick C disease

Area of Science:

• Biochemistry
• Genetics
• Metabolomics

Background:

• Niemann-Pick C disease (NPC) is a lysosomal storage disorder.
• It results from NPC1 or NPC2 gene mutations, leading to cholesterol and glycosphingolipid accumulation.
• Understanding NPC's lipid metabolism disruption is crucial for diagnosis and treatment.

Purpose of the Study:

• To investigate lipid metabolism alterations in Niemann-Pick C disease patients.
• To identify novel lipid biomarkers for NPC diagnosis.
• To gain insights into the disease's pathophysiology.

Main Methods:

• Quantitative lipidomic analysis of plasma samples from 15 NPC patients and 15 controls using Ion Mobility Mass Spectrometry.
• Analysis of oxysterols and lyso-sphingolipids using LC-MS/MS.
• Statistical analysis to differentiate between patient and control groups.

Main Results:

• Significant lipidomic differences were observed between NPC patients and controls.
• Elevated levels of arachidonic acid and diacylglycerols were found in NPC patients.
• Decreased levels of sphingomyelins, phosphatidylethanolamines, phosphatidylcholines, cholesterylesters, and lactosylceramides were noted, alongside increased oxysterols and lyso-sphingolipids.

Conclusions:

• A novel lipid biosignature for Niemann-Pick C disease was identified.
• These findings suggest potential new diagnostic biomarkers for NPC.
• Altered lipid molecules provide insights into NPC's inflammatory and oxidative stress pathways.